Associated Papers
BRAF mutant appendiceal adenocarcinoma differs from colorectal cancer but responds to BRAF-targeted therapy.
Pattalachinti VK et al.
Npj Precision Oncology, 2025
39910160 (PubMed )
Supplement: 41698_2025_821_MOESM1_ESM.pdf
Alterations in signaling pathways that accompany spontaneous transition to malignancy in a mouse model of BRAF mutant microsatellite stable colorectal cancer.
Kane AM et al.
Neoplasia (new York, N.y.), 2020
31935636 (PubMed )
Supplement: mmc2.xlsx › Sheet1
Select a paper to view details